Comprehensive Cancer Panel

Early Detection. Genetic Insights. Personalized Prevention

Our advanced cancer testing combines cutting-edge blood-based and genetic tools to provide a proactive approach to early detection and personalized cancer risk management.

Multi-Cancer Early Detection (MCED)

Galleri® Test (by GRAIL)
  • A blood test that uses methylation patterns to detect signals associated with >50 types of cancer.
  • Intended for adults 50+ years or those at elevated risk.
  • Provides a “cancer signal detected / not detected” result, with tissue of origin prediction.
  • FSA/HSA Eligible

Genetic Testing for Cancer Risk

Hereditary Cancer Panels
  • Panels typically test 30–80 genes associated with hereditary cancer risk (BRCA1/2, TP53, Lynch syndrome genes, etc.).
  • Identify individuals with a significantly elevated lifetime cancer risk.
  • Testing can guide personalized screening (e.g., earlier colonoscopies, breast MRI).
  • One-time test usually not repeated unless new panels are indicated.

Standard Tumor Markers (used selectively, not for population screening)

  • PSA (prostate), CA-125 (ovarian), CEA, AFP, CA 19-9.
  • Use only for high-risk groups or symptom evaluation.

Discover risks before they become realities

We combine genetic analysis, biomarker mapping, and personalized prevention strategies to help you stay ahead of cancer—long before symptoms appear.

COST: $1,500–$4,000

Ideal for: Individuals with family history, executives, proactive health seekers.

Select referring doctor:

Your Cart

×
Referring Doctor Test Name Price
Rajeev Khanna, MD Galleri® Test $2000

Subtotal: $2000.00